Medpace Holdings, Inc. SEC filings MEDP
Medpace Holdings, Inc. has 930 filings in SEC EDGAR's recent list, going back to Mar 15, 2016. Its latest annual report, Form ARS, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 22, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (results of operations, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Mar 5, 2020 | — |
| SC TO-T/A | Filing | Sep 17, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 20, 2019 | — |
| SC 14D9/A | Filing | Aug 20, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 19, 2019 | — |
| SC TO-T/A | Filing | Aug 15, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 9, 2019 | — |
| SC 14D9 | Filing | Aug 8, 2019 | — |
| SC TO-T/A | Filing | Aug 7, 2019 | — |
| CORRESP | Letter to the SEC | Jul 29, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 26, 2019 | — |
| EFFECT | Filing | Oct 23, 2017 | — |
| CORRESP | Letter to the SEC | Oct 18, 2017 | — |
| CORRESP | Letter to the SEC | Oct 4, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 4, 2017 | — |
| CORRESP | Letter to the SEC | Sep 20, 2017 | — |
| UPLOAD | Letter from the SEC | Sep 18, 2017 | — |
| EFFECT | Filing | Aug 10, 2016 | — |
| CERTNAS | Auto-generated paper document | Aug 10, 2016 | — |
| 8-A12B | Filing | Aug 9, 2016 | — |
| CORRESP | Letter to the SEC | Aug 8, 2016 | — |
| CORRESP | Letter to the SEC | Aug 8, 2016 | — |
| CORRESP | Letter to the SEC | Jul 28, 2016 | — |
| CORRESP | Letter to the SEC | Jul 15, 2016 | — |
| UPLOAD | Letter from the SEC | Jul 11, 2016 | — |
| CORRESP | Letter to the SEC | Jul 1, 2016 | — |
| CORRESP | Letter to the SEC | Jun 24, 2016 | — |
| DRSLTR | Filing | Jun 10, 2016 | — |
| UPLOAD | Letter from the SEC | Jun 2, 2016 | — |
| DRSLTR | Filing | May 25, 2016 | — |
| DRS/A | Filing | May 25, 2016 | — |
| UPLOAD | Letter from the SEC | May 6, 2016 | — |
| DRSLTR | Filing | Apr 27, 2016 | — |
| DRS/A | Filing | Apr 27, 2016 | — |
| UPLOAD | Letter from the SEC | Apr 12, 2016 | — |
| DRSLTR | Filing | Mar 15, 2016 | — |
| DRS | Filing | Mar 15, 2016 | — |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- MEDP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cincinnati, OH
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1668397
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- NRC Health NRC
- Maxcyte, Inc. MXCT
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.